| 一般的な頻出語を「文章内」のリストから除外しています |
| 2語前 |
1語前 |
|
1語後 |
2語後 |
|
文章内 |
| of |
37 |
have |
45 |
|
possible |
189 |
to |
467 |
|
possible |
202 |
| and |
31 |
which |
45 |
|
difficult |
143 |
for |
92 |
|
difficult |
164 |
| the |
24 |
has |
44 |
|
a |
131 |
attractive |
34 |
|
high |
102 |
| this |
19 |
that |
32 |
|
an |
79 |
promising |
25 |
|
however |
87 |
| in |
17 |
and |
27 |
|
challenging |
53 |
ideal |
22 |
|
challenging |
64 |
| to |
13 |
this |
19 |
|
suitable |
22 |
potential |
18 |
|
target |
64 |
| these |
9 |
to |
15 |
|
the |
18 |
that |
18 |
|
cell |
60 |
| are |
7 |
thus |
15 |
|
more |
18 |
difficult |
15 |
|
data |
56 |
| cell |
7 |
also |
11 |
|
easier |
17 |
of |
12 |
|
studies |
54 |
| that |
6 |
will |
9 |
|
impossible |
13 |
powerful |
11 |
|
potential |
49 |
| technology |
6 |
method |
8 |
|
necessary |
10 |
suited |
11 |
|
protein |
48 |
| which |
6 |
can |
8 |
|
hard |
10 |
valuable |
10 |
|
use |
47 |
| advances |
6 |
thereby |
8 |
|
highly |
9 |
important |
10 |
|
attractive |
46 |
| cells |
5 |
may |
7 |
|
unclear |
9 |
suitable |
8 |
|
low |
46 |
| our |
5 |
system |
5 |
|
attractive |
8 |
useful |
8 |
|
large |
45 |
| with |
5 |
technology |
5 |
|
one |
8 |
convenient |
7 |
|
single |
43 |
| human |
5 |
resolution |
5 |
|
important |
8 |
as |
6 |
|
time |
43 |
| method |
5 |
cells |
5 |
|
ideal |
7 |
most |
6 |
|
complex |
42 |
| protein |
5 |
are |
5 |
|
useful |
7 |
unique |
5 |
|
s |
42 |
| imaging |
4 |
it |
5 |
|
feasible |
6 |
key |
5 |
|
different |
42 |
| rna |
4 |
data |
4 |
|
potentially |
6 |
whether |
5 |
|
tool |
41 |
| for |
4 |
approach |
4 |
|
very |
6 |
and |
5 |
|
new |
40 |
| gene |
4 |
cancers |
4 |
|
to |
5 |
challenging |
5 |
|
applications |
40 |
| viral |
4 |
disease |
4 |
|
well |
5 |
the |
4 |
|
specific |
39 |
| techniques |
4 |
technologies |
4 |
|
particularly |
5 |
with |
4 |
|
model |
39 |
| or |
4 |
now |
4 |
|
clear |
5 |
applicable |
4 |
|
disease |
39 |
| structural |
4 |
process |
3 |
|
imperative |
5 |
interesting |
3 |
|
clinical |
39 |
| technologies |
4 |
by |
3 |
|
less |
4 |
feasible |
3 |
|
recent |
38 |
| time |
3 |
could |
3 |
|
practical |
4 |
likely |
3 |
|
other |
38 |
| not |
3 |
tissue |
3 |
|
capable |
4 |
which |
3 |
|
cells |
37 |
| across |
3 |
should |
3 |
|
essential |
4 |
excellent |
3 |
|
method |
37 |
| it |
3 |
sequencing |
3 |
|
easy |
4 |
high |
3 |
|
suitable |
36 |
| materials |
3 |
features |
3 |
|
critical |
4 |
candidate |
3 |
|
system |
36 |
| 2 |
3 |
samples |
3 |
|
promising |
4 |
critical |
3 |
|
structure |
34 |
| on |
3 |
studies |
3 |
|
ideally |
4 |
easy |
3 |
|
gene |
34 |
| spatial |
3 |
assay |
3 |
|
harder |
4 |
accessible |
3 |
|
using |
34 |
| mum |
3 |
properties |
3 |
|
appear |
4 |
not |
3 |
|
well |
33 |
| seq |
3 |
time |
3 |
|
unsuitable |
3 |
clinical |
3 |
|
important |
33 |
| high |
3 |
processes |
3 |
|
increasingly |
3 |
possible |
3 |
|
promising |
32 |
| would |
3 |
2 |
3 |
|
impractical |
3 |
a |
2 |
|
based |
32 |
| has |
3 |
databases |
3 |
|
almost |
3 |
sensitive |
2 |
|
human |
32 |
| efficiency |
3 |
control |
3 |
|
amenable |
3 |
significant |
2 |
|
ideal |
32 |
| framework |
3 |
potentially |
3 |
|
is |
3 |
susceptible |
2 |
|
small |
31 |
| data |
3 |
sequences |
3 |
|
broadly |
3 |
appealing |
2 |
|
identify |
31 |
| properties |
3 |
unknown |
3 |
|
extremely |
3 |
in |
2 |
|
study |
31 |
| cancer |
3 |
types |
3 |
|
crucial |
3 |
more |
2 |
|
during |
30 |
| measurement |
2 |
model |
3 |
|
accessible |
3 |
impossible |
2 |
|
candidate |
30 |
| during |
2 |
factors |
3 |
|
seem |
2 |
how |
2 |
|
into |
29 |
| involved |
2 |
datasets |
3 |
|
into |
2 |
leading |
2 |
|
changes |
29 |
| disulfide |
2 |
microscopy |
2 |
|
central |
2 |
accurate |
2 |
|
molecular |
29 |
| hz |
2 |
mutations |
2 |
|
preferable |
2 |
very |
2 |
|
therapeutic |
29 |
| particles |
2 |
bonds |
2 |
|
plausible |
2 |
if |
2 |
|
advances |
29 |
| small |
2 |
molecules |
2 |
|
cumbersome |
2 |
extremely |
2 |
|
highly |
28 |
| issues |
2 |
decision |
2 |
|
available |
2 |
good |
2 |
|
only |
28 |
| disease |
2 |
however |
2 |
|
rational |
2 |
from |
2 |
|
one |
27 |
| well |
2 |
cavity |
2 |
|
compatible |
2 |
low |
2 |
|
activity |
27 |
| information |
2 |
effects |
2 |
|
applicable |
2 |
highly |
2 |
|
development |
27 |
| rates |
2 |
species |
2 |
|
unlikely |
2 |
unlikely |
1 |
|
many |
27 |
| often |
2 |
often |
2 |
|
clinically |
2 |
time |
1 |
|
methods |
27 |
| serum |
2 |
reactions |
2 |
|
desirable |
2 |
easier |
1 |
|
role |
27 |
| sexual |
2 |
consuming |
2 |
|
likely |
2 |
unable |
1 |
|
across |
27 |
| regulation |
2 |
5 |
2 |
|
unique |
2 |
dependent |
1 |
|
unique |
26 |
| diversity |
2 |
activity |
2 |
|
incapable |
1 |
near |
1 |
|
resolution |
26 |
| biochemical |
2 |
size |
2 |
|
much |
1 |
than |
1 |
|
properties |
26 |
| r |
2 |
precision |
2 |
|
intrinsically |
1 |
desirable |
1 |
|
genetic |
26 |
| dna |
2 |
vertebrates |
2 |
|
application |
1 |
longer |
1 |
|
cancer |
26 |
| ct |
2 |
therapies |
2 |
|
exquisitely |
1 |
increasingly |
1 |
|
drug |
26 |
| like |
2 |
responses |
2 |
|
no |
1 |
determine |
1 |
|
binding |
25 |
| o |
2 |
limitations |
2 |
|
cannot |
1 |
routinely |
1 |
|
analysis |
25 |
| learning |
2 |
cost |
2 |
|
timely |
1 |
relevant |
1 |
|
both |
25 |
| changes |
2 |
levels |
2 |
|
unparalleled |
1 |
impractical |
1 |
|
results |
25 |
| their |
2 |
states |
2 |
|
quantification |
1 |
capable |
1 |
|
thus |
24 |
| clinical |
2 |
would |
2 |
|
selective |
1 |
commodity |
1 |
|
mechanisms |
24 |
| 15 |
2 |
selectivity |
2 |
|
cytotoxic |
1 |
both |
1 |
|
interactions |
24 |
| low |
2 |
signaling |
2 |
|
impervious |
1 |
adaptable |
1 |
|
systems |
24 |
| developed |
2 |
unclear |
2 |
|
readily |
1 |
dynamic |
1 |
|
used |
24 |
| thus |
2 |
adaptations |
2 |
|
adoptable |
1 |
clear |
1 |
|
effects |
24 |
| immune |
2 |
processing |
2 |
|
resistant |
1 |
rare |
1 |
|
associated |
23 |
| biological |
2 |
steps |
2 |
|
abundantly |
1 |
characteristic |
1 |
|
nature |
23 |
| free |
2 |
sensitivity |
2 |
|
infeasible |
1 |
optimal |
1 |
|
multiple |
23 |
| monitoring |
2 |
recently |
2 |
|
evolutionarily |
1 |
drug |
1 |
|
scale |
23 |
| synthetic |
2 |
4 |
2 |
|
even |
1 |
an |
1 |
|
cost |
23 |
| temporal |
2 |
genome |
2 |
|
as |
1 |
via |
1 |
|
species |
23 |
| cost |
2 |
3 |
2 |
|
susceptible |
1 |
equal |
1 |
|
information |
23 |
| visible |
2 |
ones |
2 |
|
too |
1 |
economical |
1 |
|
show |
23 |
| methods |
2 |
host |
2 |
|
daunting |
1 |
cost |
1 |
|
models |
22 |
| detailed |
2 |
place |
2 |
|
isoelectronic |
1 |
frequent |
1 |
|
diseases |
22 |
| coding |
2 |
mutagenesis |
2 |
|
suboptimal |
1 |
shortest |
1 |
|
two |
22 |
| developments |
2 |
not |
2 |
|
worthwhile |
1 |
reactive |
1 |
|
design |
22 |
| new |
2 |
seq |
2 |
|
inadequate |
1 |
approval |
1 |
|
often |
22 |
| phase |
2 |
sequence |
2 |
|
fundamentally |
1 |
viable |
1 |
|
critical |
22 |
| anatomical |
2 |
requirements |
2 |
|
inappropriate |
1 |
biased |
1 |
|
key |
22 |
| multiple |
2 |
resistance |
2 |
|
safe |
1 |
perfect |
1 |
|
patients |
22 |
| binding |
2 |
bias |
2 |
|
portable |
1 |
target |
1 |
|
treatment |
22 |
| have |
2 |
expression |
2 |
|
vulnerable |
1 |
well |
1 |
|
determine |
21 |
| s |
2 |
been |
2 |
|
computationally |
1 |
usable |
1 |
|
tissue |
21 |
| resulting |
2 |
conditions |
2 |
|
significantly |
1 |
indisputable |
1 |
|
genome |
21 |
| per |
2 |
results |
2 |
|
accurate |
1 |
largest |
1 |
|
features |
21 |
| order |
2 |
application |
2 |
|
comparable |
1 |
smallest |
1 |
|
over |
21 |
| current |
2 |
stimuli |
2 |
|
currently |
1 |
less |
1 |
|
without |
21 |
| cellular |
2 |
variation |
2 |
|
straightforward |
1 |
prediction |
1 |
|
understand |
21 |
| sections |
2 |
literature |
2 |
|
functional |
1 |
molecules |
1 |
|
sequencing |
21 |
| sequencing |
2 |
reads |
2 |
|
their |
1 |
plausible |
1 |
|
conditions |
21 |
| organs |
2 |
pathway |
2 |
|
vitally |
1 |
mission |
1 |
|
techniques |
20 |
| virulence |
2 |
progression |
2 |
|
treatment |
1 |
only |
1 |
|
dna |
20 |
| sampling |
2 |
year |
2 |
|
questionable |
1 |
exotic |
1 |
|
range |
20 |
| testing |
2 |
energy |
2 |
|
fast |
1 |
still |
1 |
|
imaging |
20 |
| specific |
2 |
technique |
2 |
|
relatively |
1 |
meaningful |
1 |
|
field |
20 |
| is |
2 |
overlap |
2 |
|
vital |
1 |
simple |
1 |
|
approach |
20 |
| point |
2 |
tools |
2 |
|
nearly |
1 |
ultimate |
1 |
|
processes |
20 |
| resistance |
2 |
production |
2 |
|
transparent |
1 |
great |
1 |
|
o |
20 |
| neuronal |
2 |
structure |
2 |
|
toxic |
1 |
reproducible |
1 |
|
any |
20 |
| environmental |
2 |
strains |
2 |
|
therefore |
1 |
requiring |
1 |
|
expression |
19 |
| available |
2 |
binding |
2 |
|
lose |
1 |
strongest |
1 |
|
genes |
19 |
| each |
2 |
recyclability |
2 |
|
inhibitory |
1 |
predictable |
1 |
|
complexity |
19 |
| support |
2 |
records |
1 |
|
freely |
1 |
coarse |
1 |
|
novel |
19 |
| tb |
2 |
nuclei |
1 |
|
different |
1 |
responsiveness |
1 |
|
throughput |
19 |
| range |
2 |
cartilage |
1 |
|
through |
1 |
practically |
1 |
|
proteins |
19 |
| 4 |
2 |
space |
1 |
|
electrically |
1 |
potency |
1 |
|
research |
19 |
| model |
2 |
ecosystems |
1 |
|
unfavorable |
1 |
fertile |
1 |
|
including |
19 |
| 1 |
2 |
users |
1 |
|
has |
1 |
unattractive |
1 |
|
addition |
19 |
| its |
2 |
challenges |
1 |
|
theoretically |
1 |
available |
1 |
|
understanding |
19 |
| resistant |
2 |
disorders |
1 |
|
in |
1 |
clinically |
1 |
|
individual |
19 |
| health |
1 |
delirium |
1 |
|
adaptable |
1 |
daunting |
1 |
|
long |
19 |
| fluorescence |
1 |
circumstances |
1 |
|
generally |
1 |
gluconeogenesis |
1 |
|
level |
19 |
| brain |
1 |
transform |
1 |
|
catalytic |
1 |
user |
1 |
|
structural |
19 |
| genetically |
1 |
plating |
1 |
|
similar |
1 |
tuneable |
1 |
|
e |
19 |
| events |
1 |
type |
1 |
|
way |
1 |
stable |
1 |
|
very |
19 |
| chromatids |
1 |
complex |
1 |
|
unavailable |
1 |
hormone |
1 |
|
further |
18 |
| honeydew |
1 |
shbg |
1 |
|
control |
1 |
proven |
1 |
|
sequence |
18 |
| causing |
1 |
food |
1 |
|
reduction |
1 |
tenable |
1 |
|
rna |
18 |
| genes |
1 |
metrics |
1 |
|
exhibit |
1 |
detail |
1 |
|
available |
18 |
| intermembrane |
1 |
cdpk1 |
1 |
|
convenient |
1 |
dominant |
1 |
|
impossible |
18 |
| reef |
1 |
oe |
1 |
|
acquire |
1 |
central |
1 |
|
easier |
18 |
| traces |
1 |
emphysema |
1 |
|
run |
1 |
domain |
1 |
|
detection |
18 |
| myocardium |
1 |
ml |
1 |
|
now |
1 |
efficient |
1 |
|
number |
18 |
| ubifast |
1 |
c |
1 |
|
noticeably |
1 |
quantitative |
1 |
|
immune |
18 |
| expert |
1 |
635 |
1 |
|
additionally |
1 |
into |
1 |
|
several |
18 |
| cas9_trex2 |
1 |
known |
1 |
|
far |
1 |
potentially |
1 |
|
develop |
18 |
| process |
1 |
tauopathy |
1 |
|
retrievable |
1 |
product |
1 |
|
even |
18 |
| psychiatric |
1 |
5d |
1 |
|
only |
1 |
21 |
1 |
|
each |
18 |
| treat |
1 |
pandemic |
1 |
|
able |
1 |
favourable |
1 |
|
cellular |
18 |
| when |
1 |
etiologies |
1 |
|
therapeutic |
1 |
smaller |
1 |
|
function |
18 |
| nonepileptogenic |
1 |
balanced |
1 |
|
better |
1 |
too |
1 |
|
all |
18 |
| neurotransmission |
1 |
oil |
1 |
|
acoustically |
1 |
formidable |
1 |
|
dynamics |
17 |
| depression |
1 |
planet |
1 |
|
ready |
1 |
molecular |
1 |
|
brain |
17 |
| genomics |
1 |
manifold |
1 |
|
immensely |
1 |
targeting |
1 |
|
predict |
17 |
| tree |
1 |
rise |
1 |
|
constitutively |
1 |
appearing |
1 |
|
samples |
17 |
| ptru |
1 |
platyrrhini |
1 |
|
invariant |
1 |
non |
1 |
|
non |
17 |
| mitoesq |
1 |
level |
1 |
|
agricultural |
1 |
inactive |
1 |
|
rapid |
17 |
| hbn |
1 |
industry |
1 |
|
notoriously |
1 |
method |
1 |
|
control |
17 |
| linker |
1 |
so |
1 |
|
safer |
1 |
first |
1 |
|
useful |
17 |
| ms |
1 |
labrum |
1 |
|
cost |
1 |
production |
1 |
|
measure |
17 |
| proteomics |
1 |
thermogenesis |
1 |
|
first |
1 |
effective |
1 |
|
g |
17 |
| pathway |
1 |
electrochemistry |
1 |
|
procedures |
1 |
problematic |
1 |
|
present |
17 |
| 26 |
1 |
lqts |
1 |
|
arguably |
1 |
simpler |
1 |
|
response |
17 |
| vaccine |
1 |
glyco |
1 |
|
competitive |
1 |
controllable |
1 |
|
lack |
17 |
| 19 |
1 |
heterogeneous |
1 |
|
widely |
1 |
through |
1 |
|
types |
17 |
| oral |
1 |
frequency |
1 |
|
pass |
1 |
crucial |
1 |
|
detect |
16 |
| bran |
1 |
domain |
1 |
|
open |
1 |
mechanism |
1 |
|
c |
16 |
| forces |
1 |
shortcoming |
1 |
|
|
|
source |
1 |
|
powerful |
16 |
| pharmaceutical |
1 |
ice |
1 |
|
|
|
prime |
1 |
|
efficient |
16 |
| october |
1 |
polyphosphatases |
1 |
|
|
|
|
|
|
assess |
16 |
| photonic |
1 |
maturity |
1 |
|
|
|
|
|
|
no |
16 |
| relationship |
1 |
differentiation |
1 |
|
|
|
|
|
|
technology |
16 |
| polygynous |
1 |
efficient |
1 |
|
|
|
|
|
|
some |
16 |
| aggregates |
1 |
vivo |
1 |
|
|
|
|
|
|
up |
16 |
| depletion |
1 |
gbm |
1 |
|
|
|
|
|
|
mechanism |
16 |
| msfragger |
1 |
models |
1 |
|
|
|
|
|
|
biological |
16 |
| eruptive |
1 |
ubiquitously |
1 |
|
|
|
|
|
|
factors |
16 |
| ww |
1 |
histology |
1 |
|
|
|
|
|
|
underlying |
16 |
| sea |
1 |
thickens |
1 |
|
|
|
|
|
|
need |
16 |
| hpsgn |
1 |
gbid |
1 |
|
|
|
|
|
|
researchers |
16 |
| redox |
1 |
performance |
1 |
|
|
|
|
|
|
tools |
16 |
| extremely |
1 |
lanthanum |
1 |
|
|
|
|
|
|
resource |
15 |
| surveillance |
1 |
functionality |
1 |
|
|
|
|
|
|
i |
15 |
| angular |
1 |
symbols |
1 |
|
|
|
|
|
|
under |
15 |
| ppv |
1 |
index |
1 |
|
|
|
|
|
|
process |
15 |
| xenograft |
1 |
nodes |
1 |
|
|
|
|
|
|
less |
15 |
| energy |
1 |
disrupted |
1 |
|
|
|
|
|
|
sensitivity |
15 |
| single |
1 |
pathways |
1 |
|
|
|
|
|
|
easy |
15 |
| availability |
1 |
concentration |
1 |
|
|
|
|
|
|
potentially |
15 |
| concern |
1 |
plates |
1 |
|
|
|
|
|
|
necessary |
15 |
| progress |
1 |
principle |
1 |
|
|
|
|
|
|
various |
15 |
| relationships |
1 |
systems |
1 |
|
|
|
|
|
|
characterize |
15 |
| processes |
1 |
osteointegration |
1 |
|
|
|
|
|
|
existing |
15 |
| herbivore |
1 |
complexes |
1 |
|
|
|
|
|
|
surface |
15 |
| visualization |
1 |
kernel |
1 |
|
|
|
|
|
|
chemical |
15 |
| 3 |
1 |
concepts |
1 |
|
|
|
|
|
|
host |
15 |
| glycemic |
1 |
barriers |
1 |
|
|
|
|
|
|
directly |
14 |
| approaches |
1 |
who |
1 |
|
|
|
|
|
|
dependent |
14 |
| view |
1 |
formation |
1 |
|
|
|
|
|
|
network |
14 |
| numerous |
1 |
mechanisms |
1 |
|
|
|
|
|
|
evolution |
14 |
| be |
1 |
isolation |
1 |
|
|
|
|
|
|
experimental |
14 |
| alone |
1 |
workflows |
1 |
|
|
|
|
|
|
effective |
14 |
| 98 |
1 |
procedures |
1 |
|
|
|
|
|
|
m |
14 |
| infrastructure |
1 |
selection |
1 |
|
|
|
|
|
|
sensitive |
14 |
| superior |
1 |
safety |
1 |
|
|
|
|
|
|
x |
14 |
| inactivation |
1 |
hits |
1 |
|
|
|
|
|
|
drugs |
14 |
| but |
1 |
documented |
1 |
|
|
|
|
|
|
state |
14 |
| editing |
1 |
cytoplasm |
1 |
|
|
|
|
|
|
n |
14 |
| gold |
1 |
epitope |
1 |
|
|
|
|
|
|
signaling |
14 |
| software |
1 |
reconsolidation |
1 |
|
|
|
|
|
|
energy |
14 |
| hfhs |
1 |
methylation |
1 |
|
|
|
|
|
|
materials |
14 |
| disciplines |
1 |
research |
1 |
|
|
|
|
|
|
essential |
14 |
| microscopic |
1 |
isolates |
1 |
|
|
|
|
|
|
distinguish |
14 |
| methylation |
1 |
monocaprin |
1 |
|
|
|
|
|
|
resistance |
14 |
| between |
1 |
exons |
1 |
|
|
|
|
|
|
hiv |
14 |
| analytical |
1 |
methodology |
1 |
|
|
|
|
|
|
technologies |
14 |
| insufficient |
1 |
fuels |
1 |
|
|
|
|
|
|
genomic |
13 |
| sahara |
1 |
staging |
1 |
|
|
|
|
|
|
significant |
13 |
| developmental |
1 |
carmen |
1 |
|
|
|
|
|
|
because |
13 |
| art |
1 |
outbreaks |
1 |
|
|
|
|
|
|
limited |
13 |
| large |
1 |
convention |
1 |
|
|
|
|
|
|
against |
13 |
| 11801 |
1 |
mic |
1 |
|
|
|
|
|
|
compared |
13 |
| targeted |
1 |
targets |
1 |
|
|
|
|
|
|
mediated |
13 |
| athletes |
1 |
s |
1 |
|
|
|
|
|
|
induced |
13 |
| ecological |
1 |
mcc |
1 |
|
|
|
|
|
|
particularly |
13 |
| antibody |
1 |
families |
1 |
|
|
|
|
|
|
provide |
13 |
| pfwo |
1 |
replicates |
1 |
|
|
|
|
|
|
responses |
13 |
| aforementioned |
1 |
cytosine |
1 |
|
|
|
|
|
|
better |
13 |
| assay |
1 |
future |
1 |
|
|
|
|
|
|
investigate |
13 |
| simulation |
1 |
environment |
1 |
|
|
|
|
|
|
virus |
13 |
| ev |
1 |
worldwide |
1 |
|
|
|
|
|
|
suited |
13 |
| neutralizing |
1 |
smoking |
1 |
|
|
|
|
|
|
growth |
13 |
| dependent |
1 |
publication |
1 |
|
|
|
|
|
|
like |
13 |
| cg |
1 |
7 |
1 |
|
|
|
|
|
|
natural |
13 |
| types |
1 |
subunit |
1 |
|
|
|
|
|
|
due |
13 |
| systematic |
1 |
motifs |
1 |
|
|
|
|
|
|
quality |
13 |
| stay |
1 |
probe |
1 |
|
|
|
|
|
|
major |
13 |
| different |
1 |
networks |
1 |
|
|
|
|
|
|
approaches |
13 |
| diverse |
1 |
soils |
1 |
|
|
|
|
|
|
through |
13 |
| familiarity |
1 |
10 |
1 |
|
|
|
|
|
|
hard |
13 |
| exciton |
1 |
water |
1 |
|
|
|
|
|
|
selection |
13 |
| degradation |
1 |
images |
1 |
|
|
|
|
|
|
tumor |
13 |
| antibiotic |
1 |
solution |
1 |
|
|
|
|
|
|
size |
12 |
| kornfeld |
1 |
capillaries |
1 |
|
|
|
|
|
|
events |
12 |
| mrna |
1 |
hard |
1 |
|
|
|
|
|
|
loss |
12 |
| nano |
1 |
plasticity |
1 |
|
|
|
|
|
|
obtain |
12 |
| gilbert |
1 |
generalizable |
1 |
|
|
|
|
|
|
regulatory |
12 |
| behaviour |
1 |
snzvi |
1 |
|
|
|
|
|
|
about |
12 |
| findings |
1 |
rarity |
1 |
|
|
|
|
|
|
risk |
12 |
| gelatinization |
1 |
metals |
1 |
|
|
|
|
|
|
intervention |
12 |
| modified |
1 |
conductance |
1 |
|
|
|
|
|
|
effect |
12 |
| datasets |
1 |
genuinely |
1 |
|
|
|
|
|
|
current |
12 |
| autopots |
1 |
ambiguous |
1 |
|
|
|
|
|
|
known |
12 |
| near |
1 |
diet |
1 |
|
|
|
|
|
|
although |
12 |
| remained |
1 |
modifications |
1 |
|
|
|
|
|
|
formation |
12 |
| births |
1 |
section |
1 |
|
|
|
|
|
|
increase |
12 |
| physiological |
1 |
rif |
1 |
|
|
|
|
|
|
water |
12 |
| cigarette |
1 |
others |
1 |
|
|
|
|
|
|
knowledge |
12 |
| acid |
1 |
constraints |
1 |
|
|
|
|
|
|
valuable |
12 |
| te |
1 |
alternatives |
1 |
|
|
|
|
|
|
vivo |
12 |
| ggamma |
1 |
taste |
1 |
|
|
|
|
|
|
receptor |
12 |
| multilayered |
1 |
information |
1 |
|
|
|
|
|
|
seq |
12 |
| roll |
1 |
immunogenic |
1 |
|
|
|
|
|
|
crucial |
12 |
| most |
1 |
reagents |
1 |
|
|
|
|
|
|
find |
12 |
| package |
1 |
ixabepilone |
1 |
|
|
|
|
|
|
temperature |
12 |
| presentation |
1 |
life |
1 |
|
|
|
|
|
|
platform |
12 |
| molecules |
1 |
applications |
1 |
|
|
|
|
|
|
allows |
12 |
| thermal |
1 |
science |
1 |
|
|
|
|
|
|
functions |
12 |
| marine |
1 |
radiation |
1 |
|
|
|
|
|
|
point |
12 |
| particle |
1 |
today |
1 |
|
|
|
|
|
|
diversity |
11 |
| immortalization |
1 |
measurements |
1 |
|
|
|
|
|
|
availability |
11 |
| epl |
1 |
foundation |
1 |
|
|
|
|
|
|
microscopy |
11 |
| evs |
1 |
hrt |
1 |
|
|
|
|
|
|
type |
11 |
| radiation |
1 |
gelation |
1 |
|
|
|
|
|
|
space |
11 |
| ruo |
1 |
group |
1 |
|
|
|
|
|
|
plant |
11 |
| features |
1 |
mdr |
1 |
|
|
|
|
|
|
efficiency |
11 |
| yeast |
1 |
profile |
1 |
|
|
|
|
|
|
evaluate |
11 |
| transition |
1 |
microtubules |
1 |
|
|
|
|
|
|
involved |
11 |
| channel |
1 |
rrms |
1 |
|
|
|
|
|
|
neural |
11 |
| interventions |
1 |
trafficking |
1 |
|
|
|
|
|
|
methylation |
11 |
| presented |
1 |
importance |
1 |
|
|
|
|
|
|
currently |
11 |
| risk |
1 |
analytes |
1 |
|
|
|
|
|
|
food |
11 |
| network |
1 |
rna |
1 |
|
|
|
|
|
|
wide |
11 |
| same |
1 |
motif |
1 |
|
|
|
|
|
|
viral |
11 |
| validated |
1 |
meat |
1 |
|
|
|
|
|
|
membrane |
11 |
| columns |
1 |
itch |
1 |
|
|
|
|
|
|
molecules |
11 |
| tissue |
1 |
cysteine |
1 |
|
|
|
|
|
|
contrast |
11 |
| than |
1 |
separation |
1 |
|
|
|
|
|
|
pathway |
11 |
| content |
1 |
novelty |
1 |
|
|
|
|
|
|
unclear |
11 |
| space |
1 |
hours |
1 |
|
|
|
|
|
|
moreover |
11 |
| taken |
1 |
preferences |
1 |
|
|
|
|
|
|
functional |
11 |
| kinetic |
1 |
pressure |
1 |
|
|
|
|
|
|
light |
11 |
| training |
1 |
expand |
1 |
|
|
|
|
|
|
pathways |
11 |
| strongly |
1 |
pattern |
1 |
|
|
|
|
|
|
generation |
11 |
| hybridization |
1 |
being |
1 |
|
|
|
|
|
|
specificity |
11 |
| laboratory |
1 |
search |
1 |
|
|
|
|
|
|
three |
11 |
| family |
1 |
tomatoes |
1 |
|
|
|
|
|
|
infection |
11 |
| early |
1 |
domains |
1 |
|
|
|
|
|
|
resistant |
11 |
| equality |
1 |
equipment |
1 |
|
|
|
|
|
|
developed |
11 |
| ionizing |
1 |
pseudoreplication |
1 |
|
|
|
|
|
|
what |
11 |
| used |
1 |
organisms |
1 |
|
|
|
|
|
|
therefore |
11 |
| tending |
1 |
containers |
1 |
|
|
|
|
|
|
findings |
11 |
| fusion |
1 |
chemistry |
1 |
|
|
|
|
|
|
sequences |
11 |
| lower |
1 |
immortalization |
1 |
|
|
|
|
|
|
processing |
11 |
| acids |
1 |
c3 |
1 |
|
|
|
|
|
|
ability |
11 |
| m2e |
1 |
biology |
1 |
|
|
|
|
|
|
furthermore |
10 |
| nh |
1 |
moulds |
1 |
|
|
|
|
|
|
unknown |
10 |
| anchor |
1 |
colonoscopy |
1 |
|
|
|
|
|
|
mutations |
10 |
| mediated |
1 |
constructs |
1 |
|
|
|
|
|
|
future |
10 |
| safety |
1 |
publications |
1 |
|
|
|
|
|
|
feasible |
10 |
| nk |
1 |
pathogenesis |
1 |
|
|
|
|
|
|
measurement |
10 |
| dialysis |
1 |
day |
1 |
|
|
|
|
|
|
related |
10 |
| transneuronal |
1 |
interpret |
1 |
|
|
|
|
|
|
decision |
10 |
| relative |
1 |
lines |
1 |
|
|
|
|
|
|
care |
10 |
| any |
1 |
amyloid |
1 |
|
|
|
|
|
|
suggest |
10 |
| quality |
1 |
tail |
1 |
|
|
|
|
|
|
concentration |
10 |
| efficient |
1 |
voltage |
1 |
|
|
|
|
|
|
fold |
10 |
| automation |
1 |
oct |
1 |
|
|
|
|
|
|
beta |
10 |
| ytry |
1 |
surface |
1 |
|
|
|
|
|
|
levels |
10 |
| ratios |
1 |
implementations |
1 |
|
|
|
|
|
|
site |
10 |
| rabbit |
1 |
mas |
1 |
|
|
|
|
|
|
life |
10 |
| subdisciplines |
1 |
transcription |
1 |
|
|
|
|
|
|
population |
10 |
| subsequent |
1 |
sensor |
1 |
|
|
|
|
|
|
profiles |
10 |
| studies |
1 |
paper |
1 |
|
|
|
|
|
|
observed |
10 |
| habitat |
1 |
determinants |
1 |
|
|
|
|
|
|
performance |
10 |
| rainfall |
1 |
metabolites |
1 |
|
|
|
|
|
|
diverse |
10 |
| clearly |
1 |
k |
1 |
|
|
|
|
|
|
h |
10 |
| strength |
1 |
multiguidescan |
1 |
|
|
|
|
|
|
dynamic |
10 |
| invasion |
1 |
parts |
1 |
|
|
|
|
|
|
networks |
10 |
| measured |
1 |
assimilation |
1 |
|
|
|
|
|
|
factor |
10 |
| complex |
1 |
suspension |
1 |
|
|
|
|
|
|
targets |
10 |
| conditions |
1 |
stresses |
1 |
|
|
|
|
|
|
genomes |
10 |
| sensitive |
1 |
state |
1 |
|
|
|
|
|
|
fast |
10 |
| instructions |
1 |
dmndc |
1 |
|
|
|
|
|
|
convenient |
10 |
| defect |
1 |
learning |
1 |
|
|
|
|
|
|
ion |
10 |
| pandemic |
1 |
iga1 |
1 |
|
|
|
|
|
|
spatial |
10 |
| at |
1 |
ratio |
1 |
|
|
|
|
|
|
peptide |
10 |
| after |
1 |
filtering |
1 |
|
|
|
|
|
|
thereby |
10 |
| 000 |
1 |
response |
1 |
|
|
|
|
|
|
patterns |
10 |
| cre |
1 |
severity |
1 |
|
|
|
|
|
|
rate |
10 |
| functional |
1 |
framework |
1 |
|
|
|
|
|
|
solution |
10 |
| stable |
1 |
populations |
1 |
|
|
|
|
|
|
activation |
10 |
| residue |
1 |
drifts |
1 |
|
|
|
|
|
|
recently |
10 |
| driving |
1 |
extinct |
1 |
|
|
|
|
|
|
work |
10 |
| various |
1 |
mmhg |
1 |
|
|
|
|
|
|
compare |
10 |
| ao |
1 |
motility |
1 |
|
|
|
|
|
|
rapidly |
10 |
| elucidated |
1 |
bottleneck |
1 |
|
|
|
|
|
|
health |
9 |
| motion |
1 |
product |
1 |
|
|
|
|
|
|
structures |
9 |
| fus |
1 |
stability |
1 |
|
|
|
|
|
|
years |
9 |
| bacilli |
1 |
earth |
1 |
|
|
|
|
|
|
if |
9 |
| antigenic |
1 |
diner |
1 |
|
|
|
|
|
|
pre |
9 |
| unique |
1 |
involved |
1 |
|
|
|
|
|
|
accurate |
9 |
| filters |
1 |
mice |
1 |
|
|
|
|
|
|
being |
9 |
| experiments |
1 |
seaweeds |
1 |
|
|
|
|
|
|
signal |
9 |
| 100 |
1 |
kinases |
1 |
|
|
|
|
|
|
applicable |
9 |
| printed |
1 |
scales |
1 |
|
|
|
|
|
|
standard |
9 |
| bicelle |
1 |
complications |
1 |
|
|
|
|
|
|
relationships |
9 |
| glassy |
1 |
seizures |
1 |
|
|
|
|
|
|
visual |
9 |
| times |
1 |
al |
1 |
|
|
|
|
|
|
relevant |
9 |
| read |
1 |
repair |
1 |
|
|
|
|
|
|
proposed |
9 |
| deep |
1 |
infections |
1 |
|
|
|
|
|
|
easily |
9 |
| solvent |
1 |
gc |
1 |
|
|
|
|
|
|
mass |
9 |
| informed |
1 |
polymer |
1 |
|
|
|
|
|
|
stress |
9 |
| inflammatory |
1 |
markets |
1 |
|
|
|
|
|
|
interventions |
9 |
| symptom |
1 |
analysis |
1 |
|
|
|
|
|
|
alternative |
9 |
| zif |
1 |
duration |
1 |
|
|
|
|
|
|
central |
9 |
| formation |
1 |
nanoscale |
1 |
|
|
|
|
|
|
local |
9 |
| tables |
1 |
cerebellum |
1 |
|
|
|
|
|
|
via |
9 |
| long |
1 |
specificity |
1 |
|
|
|
|
|
|
environment |
9 |
| 21 |
1 |
unc13a |
1 |
|
|
|
|
|
|
demonstrate |
9 |
| sites |
1 |
metabolism |
1 |
|
|
|
|
|
|
evidence |
9 |
| negative |
1 |
costs |
1 |
|
|
|
|
|
|
bacterial |
9 |
| profiling |
1 |
experience |
1 |
|
|
|
|
|
|
framework |
9 |
| genetic |
1 |
stationary |
1 |
|
|
|
|
|
|
examine |
9 |
| acetylated |
1 |
myosin |
1 |
|
|
|
|
|
|
do |
9 |
| mathematical |
1 |
oxides |
1 |
|
|
|
|
|
|
optical |
9 |
| intermediates |
1 |
microfluidics |
1 |
|
|
|
|
|
|
required |
9 |
| ulva |
1 |
then |
1 |
|
|
|
|
|
|
datasets |
9 |
| chemotherapeutic |
1 |
abnormalities |
1 |
|
|
|
|
|
|
stability |
9 |
| speed |
1 |
motion |
1 |
|
|
|
|
|
|
selective |
9 |
| em |
1 |
capacity |
1 |
|
|
|
|
|
|
strategies |
9 |
| associated |
1 |
line |
1 |
|
|
|
|
|
|
source |
9 |
| efforts |
1 |
substantial |
1 |
|
|
|
|
|
|
stable |
9 |
| glycan |
1 |
hg |
1 |
|
|
|
|
|
|
electron |
9 |
| et |
1 |
scarce |
1 |
|
|
|
|
|
|
action |
9 |
| bacterial |
1 |
electrophorus |
1 |
|
|
|
|
|
|
impact |
9 |
| chemical |
1 |
death |
1 |
|
|
|
|
|
|
production |
9 |
| af |
1 |
rates |
1 |
|
|
|
|
|
|
targeted |
9 |
| suppression |
1 |
without |
1 |
|
|
|
|
|
|
co |
9 |
| neural |
1 |
cortex |
1 |
|
|
|
|
|
|
relatively |
9 |
| lipid |
1 |
infused |
1 |
|
|
|
|
|
|
computational |
9 |
| decision |
1 |
profiles |
1 |
|
|
|
|
|
|
quantitative |
9 |
| markers |
1 |
oleoresin |
1 |
|
|
|
|
|
|
assembly |
9 |
| tolerant |
1 |
stochastic |
1 |
|
|
|
|
|
|
core |
9 |
| horizontal |
1 |
14d |
1 |
|
|
|
|
|
|
material |
9 |
| sequence |
1 |
film |
1 |
|
|
|
|
|
|
replication |
9 |
| ii |
1 |
stands |
1 |
|
|
|
|
|
|
parameters |
9 |
| trials |
1 |
region |
1 |
|
|
|
|
|
|
now |
9 |
| starting |
1 |
lacking |
1 |
|
|
|
|
|
|
early |
8 |
| metal |
1 |
absorption |
1 |
|
|
|
|
|
|
users |
8 |
| cohorts |
1 |
rnas |
1 |
|
|
|
|
|
|
simple |
8 |
| anchoring |
1 |
therapeutics |
1 |
|
|
|
|
|
|
among |
8 |
| web |
1 |
contexts |
1 |
|
|
|
|
|
|
much |
8 |
| trapping |
1 |
interactions |
1 |
|
|
|
|
|
|
perform |
8 |
| jam |
1 |
too |
1 |
|
|
|
|
|
|
capable |
8 |
| ratio |
1 |
apc |
1 |
|
|
|
|
|
|
therapy |
8 |
| consequent |
1 |
fold |
1 |
|
|
|
|
|
|
therapies |
8 |
| science |
1 |
damage |
1 |
|
|
|
|
|
|
values |
8 |
| flexibility |
1 |
cytc |
1 |
|
|
|
|
|
|
statistical |
8 |
| bmem |
1 |
evolution |
1 |
|
|
|
|
|
|
molecule |
8 |
| set |
1 |
techniques |
1 |
|
|
|
|
|
|
compounds |
8 |
| container |
1 |
fragmented |
1 |
|
|
|
|
|
|
magnetic |
8 |
| visual |
1 |
lipopolysaccharides |
1 |
|
|
|
|
|
|
term |
8 |
| rapidly |
1 |
cns |
1 |
|
|
|
|
|
|
composition |
8 |
| ginger |
1 |
estimator |
1 |
|
|
|
|
|
|
given |
8 |
| dominance |
1 |
manoeuvres |
1 |
|
|
|
|
|
|
likely |
8 |
| highly |
1 |
incomplete |
1 |
|
|
|
|
|
|
technological |
8 |
| thin |
1 |
substrates |
1 |
|
|
|
|
|
|
excellent |
8 |
| correlated |
1 |
subtypes |
1 |
|
|
|
|
|
|
capability |
8 |
| analysis |
1 |
cytokinesis |
1 |
|
|
|
|
|
|
metabolic |
8 |
| catalysis |
1 |
sparing |
1 |
|
|
|
|
|
|
screening |
8 |
| field |
1 |
neuroimaging |
1 |
|
|
|
|
|
|
behavior |
8 |
| disordered |
1 |
capability |
1 |
|
|
|
|
|
|
so |
8 |
| transient |
1 |
determinant |
1 |
|
|
|
|
|
|
sources |
8 |
| pure |
1 |
regulation |
1 |
|
|
|
|
|
|
improve |
8 |
| based |
1 |
ih |
1 |
|
|
|
|
|
|
yet |
8 |
| c |
1 |
setting |
1 |
|
|
|
|
|
|
populations |
8 |
| dendritic |
1 |
status |
1 |
|
|
|
|
|
|
make |
8 |
| 20 |
1 |
ecr |
1 |
|
|
|
|
|
|
areas |
8 |
| solution |
1 |
algorithm |
1 |
|
|
|
|
|
|
roles |
8 |
| scientific |
1 |
field |
1 |
|
|
|
|
|
|
short |
8 |
| ngs |
1 |
navigation |
1 |
|
|
|
|
|
|
neuronal |
8 |
| engagement |
1 |
simultaneously |
1 |
|
|
|
|
|
|
domain |
8 |
| sms |
1 |
rdrp |
1 |
|
|
|
|
|
|
global |
8 |
| temperature |
1 |
officers |
1 |
|
|
|
|
|
|
gas |
8 |
| tools |
1 |
elevation |
1 |
|
|
|
|
|
|
sample |
8 |
| honey |
1 |
tool |
1 |
|
|
|
|
|
|
read |
8 |
| mechanisms |
1 |
researchers |
1 |
|
|
|
|
|
|
next |
8 |
| phosphorylated |
1 |
hypotension |
1 |
|
|
|
|
|
|
times |
8 |
| virus |
1 |
mechanism |
1 |
|
|
|
|
|
|
regulation |
8 |
| may |
1 |
vulnerable |
1 |
|
|
|
|
|
|
testing |
8 |
| library |
1 |
pas |
1 |
|
|
|
|
|
|
self |
8 |
| histones |
1 |
figures |
1 |
|
|
|
|
|
|
profiling |
8 |
| system |
1 |
processors |
1 |
|
|
|
|
|
|
simplicity |
8 |
| components |
1 |
strategies |
1 |
|
|
|
|
|
|
distinct |
8 |
| erratic |
1 |
school |
1 |
|
|
|
|
|
|
assay |
8 |
| glucose |
1 |
mortality |
1 |
|
|
|
|
|
|
readily |
8 |
| enzyme |
1 |
volts |
1 |
|
|
|
|
|
|
established |
8 |
| remains |
1 |
entangled |
1 |
|
|
|
|
|
|
learning |
8 |
| sample |
1 |
cooperation |
1 |
|
|
|
|
|
|
found |
8 |
| mitigation |
1 |
groups |
1 |
|
|
|
|
|
|
clear |
8 |
| we |
1 |
quantities |
1 |
|
|
|
|
|
|
simultaneously |
8 |
| pathogenic |
1 |
package |
1 |
|
|
|
|
|
|
neurons |
8 |
| feedback |
1 |
immunotherapies |
1 |
|
|
|
|
|
|
per |
8 |
| tswv |
1 |
decipher |
1 |
|
|
|
|
|
|
change |
8 |
| concept |
1 |
trcel7b |
1 |
|
|
|
|
|
|
reads |
8 |
| ice |
1 |
5beta |
1 |
|
|
|
|
|
|
cases |
8 |
| epr |
1 |
ligand |
1 |
|
|
|
|
|
|
generated |
8 |
| metagenome |
1 |
cavitation |
1 |
|
|
|
|
|
|
importance |
8 |
| valve |
1 |
events |
1 |
|
|
|
|
|
|
direct |
8 |
| unliganded |
1 |
beauv |
1 |
|
|
|
|
|
|
storage |
8 |
| computing |
1 |
order |
1 |
|
|
|
|
|
|
metal |
8 |
| metagenomic |
1 |
uca |
1 |
|
|
|
|
|
|
numbers |
8 |
| microenvironment |
1 |
15 |
1 |
|
|
|
|
|
|
density |
8 |
| transmission |
1 |
tdm |
1 |
|
|
|
|
|
|
shown |
8 |
| signal |
1 |
intervention |
1 |
|
|
|
|
|
|
thousands |
8 |
| computational |
1 |
inevitably |
1 |
|
|
|
|
|
|
extensive |
7 |
| drugs |
1 |
lethal |
1 |
|
|
|
|
|
|
precision |
7 |
| photo |
1 |
surfaces |
1 |
|
|
|
|
|
|
support |
7 |
| use |
1 |
way |
1 |
|
|
|
|
|
|
capture |
7 |
| about |
1 |
enzymes |
1 |
|
|
|
|
|
|
despite |
7 |
| composition |
1 |
microenvironment |
1 |
|
|
|
|
|
|
reported |
7 |
| manufacturing |
1 |
spoilage |
1 |
|
|
|
|
|
|
aggregation |
7 |
| gdp |
1 |
pathology |
1 |
|
|
|
|
|
|
steps |
7 |
| revolutions |
1 |
instruments |
1 |
|
|
|
|
|
|
lead |
7 |
| genome |
1 |
evasion |
1 |
|
|
|
|
|
|
compound |
7 |
| quantitative |
1 |
midzone |
1 |
|
|
|
|
|
|
10 |
7 |
| individual |
1 |
event |
1 |
|
|
|
|
|
|
algorithm |
7 |
| n |
1 |
characteristics |
1 |
|
|
|
|
|
|
full |
7 |
| intrasheet |
1 |
cases |
1 |
|
|
|
|
|
|
patient |
7 |
| orthostatic |
1 |
mo |
1 |
|
|
|
|
|
|
manage |
7 |
| distinct |
1 |
areas |
1 |
|
|
|
|
|
|
accurately |
7 |
| metabolically |
1 |
phenotype |
1 |
|
|
|
|
|
|
experiments |
7 |
| longer |
1 |
stress |
1 |
|
|
|
|
|
|
application |
7 |
| areas |
1 |
hidden |
1 |
|
|
|
|
|
|
rates |
7 |
| panel |
1 |
efficiency |
1 |
|
|
|
|
|
|
antigen |
7 |
| research |
1 |
diversified |
1 |
|
|
|
|
|
|
variability |
7 |
| pdb |
1 |
compartment |
1 |
|
|
|
|
|
|
test |
7 |
| solutions |
1 |
acute |
1 |
|
|
|
|
|
|
particles |
7 |
| behavioral |
1 |
diseases |
1 |
|
|
|
|
|
|
assays |
7 |
| mmc |
1 |
virulence |
1 |
|
|
|
|
|
|
art |
7 |
| restricted |
1 |
pocket |
1 |
|
|
|
|
|
|
view |
7 |
| excitation |
1 |
footprint |
1 |
|
|
|
|
|
|
sampling |
7 |
| dsf |
1 |
proteins |
1 |
|
|
|
|
|
|
increased |
7 |
| homogeneous |
1 |
freedom |
1 |
|
|
|
|
|
|
cancers |
7 |
| key |
1 |
before |
1 |
|
|
|
|
|
|
include |
7 |
| variability |
1 |
monocytogenes |
1 |
|
|
|
|
|
|
degrees |
7 |
| transcription |
1 |
leak |
1 |
|
|
|
|
|
|
implications |
7 |
| potential |
1 |
assays |
1 |
|
|
|
|
|
|
trials |
7 |
| pvfp |
1 |
labeling |
1 |
|
|
|
|
|
|
environmental |
7 |
| substrate |
1 |
cuticle |
1 |
|
|
|
|
|
|
mechanistic |
7 |
| receptor |
1 |
cell |
1 |
|
|
|
|
|
|
same |
7 |
| unseeded |
1 |
cyanobacteria |
1 |
|
|
|
|
|
|
profile |
7 |
| transformed |
1 |
clozapine |
1 |
|
|
|
|
|
|
products |
7 |
| shift |
1 |
dynamics |
1 |
|
|
|
|
|
|
improvements |
7 |
| limitations |
1 |
issues |
1 |
|
|
|
|
|
|
access |
7 |
| simple |
1 |
chain |
1 |
|
|
|
|
|
|
active |
7 |
| biomarkers |
1 |
exchanger |
1 |
|
|
|
|
|
|
integrated |
7 |
| possible |
1 |
contigs |
1 |
|
|
|
|
|
|
few |
7 |
| ancestor |
1 |
biochar |
1 |
|
|
|
|
|
|
stages |
7 |
| mille |
1 |
ion |
1 |
|
|
|
|
|
|
pattern |
7 |
| interaction |
1 |
resolutions |
1 |
|
|
|
|
|
|
order |
7 |
| predictable |
1 |
source |
1 |
|
|
|
|
|
|
form |
7 |
| lysosomal |
1 |
synthesis |
1 |
|
|
|
|
|
|
reaction |
7 |
| frequencies |
1 |
gap |
1 |
|
|
|
|
|
|
heterogeneous |
7 |
| oxidative |
1 |
quechers |
1 |
|
|
|
|
|
|
temporal |
7 |
| nct |
1 |
indicators |
1 |
|
|
|
|
|
|
precise |
7 |
| physiology |
1 |
frankenbody |
1 |
|
|
|
|
|
|
biochemical |
7 |
| mri |
1 |
behavior |
1 |
|
|
|
|
|
|
showed |
7 |
| destructive |
1 |
disorder |
1 |
|
|
|
|
|
|
image |
7 |
| addition |
1 |
persistence |
1 |
|
|
|
|
|
|
provides |
7 |
| spindle |
1 |
aie |
1 |
|
|
|
|
|
|
higher |
7 |
| ordered |
1 |
ago |
1 |
|
|
|
|
|
|
potent |
7 |
| an |
1 |
necessary |
1 |
|
|
|
|
|
|
combination |
7 |
| takes |
1 |
segments |
1 |
|
|
|
|
|
|
targeting |
7 |
| many |
1 |
lc |
1 |
|
|
|
|
|
|
define |
7 |
| retinal |
1 |
schizophrenia |
1 |
|
|
|
|
|
|
quantify |
7 |
| effect |
1 |
ar |
1 |
|
|
|
|
|
|
rich |
7 |
| carbonate |
1 |
shows |
1 |
|
|
|
|
|
|
regions |
7 |
| nature |
1 |
prions |
1 |
|
|
|
|
|
|
anti |
7 |
| zise |
1 |
adolescents |
1 |
|
|
|
|
|
|
sites |
7 |
| salt |
1 |
values |
1 |
|
|
|
|
|
|
discovery |
7 |
| mtor |
1 |
compensation |
1 |
|
|
|
|
|
|
generate |
7 |
| clinicopathologic |
1 |
run |
1 |
|
|
|
|
|
|
r |
7 |
| replication |
1 |
temperatures |
1 |
|
|
|
|
|
|
conformational |
7 |
| specification |
1 |
ketones |
1 |
|
|
|
|
|
|
still |
7 |
| smartphone |
1 |
pathogen |
1 |
|
|
|
|
|
|
free |
7 |
| largely |
1 |
step |
1 |
|
|
|
|
|
|
far |
7 |
| decorporation |
1 |
enb |
1 |
|
|
|
|
|
|
task |
7 |
| paper |
1 |
light |
1 |
|
|
|
|
|
|
context |
7 |
| heuristics |
1 |
butanol |
1 |
|
|
|
|
|
|
3d |
7 |
| extent |
1 |
urbanization |
1 |
|
|
|
|
|
|
resolve |
7 |
| mice |
1 |
volumes |
1 |
|
|
|
|
|
|
heterogeneity |
7 |
| recoveries |
1 |
ecdysone |
1 |
|
|
|
|
|
|
ligand |
7 |
| tumor |
1 |
proliferation |
1 |
|
|
|
|
|
|
mapping |
7 |
| beam |
1 |
h |
1 |
|
|
|
|
|
|
bacteria |
7 |
| shielding |
1 |
support |
1 |
|
|
|
|
|
|
hospice |
7 |
| growth |
1 |
koh |
1 |
|
|
|
|
|
|
blood |
7 |
| neurodegenerative |
1 |
but |
1 |
|
|
|
|
|
|
enzyme |
7 |
| over |
1 |
uvpd |
1 |
|
|
|
|
|
|
t |
7 |
| hope |
1 |
humans |
1 |
|
|
|
|
|
|
solvent |
7 |
| precision |
1 |
revolution |
1 |
|
|
|
|
|
|
transient |
6 |
| device |
1 |
complexity |
1 |
|
|
|
|
|
|
resulting |
6 |
| identity |
1 |
entries |
1 |
|
|
|
|
|
|
chromosome |
6 |
| ever |
1 |
temperature |
1 |
|
|
|
|
|
|
ii |
6 |
| detectors |
1 |
protein |
1 |
|
|
|
|
|
|
eye |
6 |
| resources |
1 |
electrolytes |
1 |
|
|
|
|
|
|
probe |
6 |
| listeria |
1 |
sers |
1 |
|
|
|
|
|
|
18 |
6 |
| depc |
1 |
intensity |
1 |
|
|
|
|
|
|
inhibitors |
6 |
| elegans |
1 |
task |
1 |
|
|
|
|
|
|
speed |
6 |
| among |
1 |
galactose |
1 |
|
|
|
|
|
|
primary |
6 |
| blood |
1 |
xenografts |
1 |
|
|
|
|
|
|
create |
6 |
| response |
1 |
inhomogeneity |
1 |
|
|
|
|
|
|
additional |
6 |
| convergence |
1 |
years |
1 |
|
|
|
|
|
|
improved |
6 |
| dqbeta |
1 |
lidar |
1 |
|
|
|
|
|
|
practical |
6 |
| heat |
1 |
study |
1 |
|
|
|
|
|
|
estimate |
6 |
| malaria |
1 |
pregnancy |
1 |
|
|
|
|
|
|
resources |
6 |
| rca |
1 |
trees |
1 |
|
|
|
|
|
|
world |
6 |
| several |
1 |
patient |
1 |
|
|
|
|
|
|
characteristics |
6 |
| detection |
1 |
plants |
1 |
|
|
|
|
|
|
normal |
6 |
| error |
1 |
development |
1 |
|
|
|
|
|
|
interesting |
6 |
| sodium |
1 |
methods |
1 |
|
|
|
|
|
|
expressed |
6 |
| known |
1 |
designer |
1 |
|
|
|
|
|
|
z |
6 |
| band |
1 |
tnbcs |
1 |
|
|
|
|
|
|
reliable |
6 |
| workbench |
1 |
|
|
|
|
|
|
|
|
analyses |
6 |
| microscopy |
1 |
|
|
|
|
|
|
|
|
matrix |
6 |
| prognostic |
1 |
|
|
|
|
|
|
|
|
reach |
6 |
| thc |
1 |
|
|
|
|
|
|
|
|
way |
6 |
| ha |
1 |
|
|
|
|
|
|
|
|
k |
6 |
| autoinflammatory |
1 |
|
|
|
|
|
|
|
|
ms |
6 |
| glomerular |
1 |
|
|
|
|
|
|
|
|
increasingly |
6 |
| emission |
1 |
|
|
|
|
|
|
|
|
cross |
6 |
| directed |
1 |
|
|
|
|
|
|
|
|
fields |
6 |
| responses |
1 |
|
|
|
|
|
|
|
|
predicted |
6 |
| years |
1 |
|
|
|
|
|
|
|
|
therapeutics |
6 |
| if |
1 |
|
|
|
|
|
|
|
|
progression |
6 |
| outer |
1 |
|
|
|
|
|
|
|
|
influence |
6 |
| flow |
1 |
|
|
|
|
|
|
|
|
particle |
6 |
| will |
1 |
|
|
|
|
|
|
|
|
does |
6 |
| 2b |
1 |
|
|
|
|
|
|
|
|
social |
6 |
| proteins |
1 |
|
|
|
|
|
|
|
|
vaccine |
6 |
| heterogenous |
1 |
|
|
|
|
|
|
|
|
severity |
6 |
| categorical |
1 |
|
|
|
|
|
|
|
|
making |
6 |
| cut |
1 |
|
|
|
|
|
|
|
|
pace |
6 |
| turnaround |
1 |
|
|
|
|
|
|
|
|
map |
6 |
| elevated |
1 |
|
|
|
|
|
|
|
|
extreme |
6 |
| graphs |
1 |
|
|
|
|
|
|
|
|
transcriptomic |
6 |
| exogenous |
1 |
|
|
|
|
|
|
|
|
weight |
6 |
| supply |
1 |
|
|
|
|
|
|
|
|
frequency |
6 |
| given |
1 |
|
|
|
|
|
|
|
|
reactions |
6 |
| reaction |
1 |
|
|
|
|
|
|
|
|
before |
6 |
| costs |
1 |
|
|
|
|
|
|
|
|
extremely |
6 |
| spectrometers |
1 |
|
|
|
|
|
|
|
|
enzymes |
6 |
| bag |
1 |
|
|
|
|
|
|
|
|
strong |
6 |
| pleotropic |
1 |
|
|
|
|
|
|
|
|
downstream |
6 |
| architecture |
1 |
|
|
|
|
|
|
|
|
negative |
6 |
| rapid |
1 |
|
|
|
|
|
|
|
|
oxygen |
6 |
| conformations |
1 |
|
|
|
|
|
|
|
|
numerous |
6 |
| treg |
1 |
|
|
|
|
|
|
|
|
particular |
6 |
| 72 |
1 |
|
|
|
|
|
|
|
|
especially |
6 |
| extracorporeal |
1 |
|
|
|
|
|
|
|
|
increasing |
6 |
| m |
1 |
|
|
|
|
|
|
|
|
plants |
6 |
| leap |
1 |
|
|
|
|
|
|
|
|
able |
6 |
| infected |
1 |
|
|
|
|
|
|
|
|
set |
6 |
| reduction |
1 |
|
|
|
|
|
|
|
|
implementation |
6 |
| industrial |
1 |
|
|
|
|
|
|
|
|
open |
6 |
| memory |
1 |
|
|
|
|
|
|
|
|
pressure |
6 |
| total |
1 |
|
|
|
|
|
|
|
|
achieve |
6 |
| alkaline |
1 |
|
|
|
|
|
|
|
|
industrial |
6 |
| patients |
1 |
|
|
|
|
|
|
|
|
multi |
6 |
| assessment |
1 |
|
|
|
|
|
|
|
|
detailed |
6 |
| light |
1 |
|
|
|
|
|
|
|
|
beyond |
6 |
| cascade |
1 |
|
|
|
|
|
|
|
|
settings |
6 |
| while |
1 |
|
|
|
|
|
|
|
|
option |
6 |
| fast |
1 |
|
|
|
|
|
|
|
|
encoded |
6 |
| hogs |
1 |
|
|
|
|
|
|
|
|
rare |
6 |
| states |
1 |
|
|
|
|
|
|
|
|
previous |
6 |
| t807 |
1 |
|
|
|
|
|
|
|
|
aspects |
6 |
| magnetic |
1 |
|
|
|
|
|
|
|
|
databases |
6 |
| glutr1 |
1 |
|
|
|
|
|
|
|
|
faster |
6 |
| recent |
1 |
|
|
|
|
|
|
|
|
substrate |
6 |
| mounted |
1 |
|
|
|
|
|
|
|
|
optimal |
6 |
| structure |
1 |
|
|
|
|
|
|
|
|
biology |
6 |
| fixing |
1 |
|
|
|
|
|
|
|
|
synthesis |
6 |
| interferences |
1 |
|
|
|
|
|
|
|
|
date |
6 |
| biomedical |
1 |
|
|
|
|
|
|
|
|
paper |
6 |
| antipruritic |
1 |
|
|
|
|
|
|
|
|
simulation |
6 |
| other |
1 |
|
|
|
|
|
|
|
|
similar |
6 |
| vivo |
1 |
|
|
|
|
|
|
|
|
performed |
6 |
| pancreas |
1 |
|
|
|
|
|
|
|
|
intrinsic |
6 |
| prevention |
1 |
|
|
|
|
|
|
|
|
selectivity |
6 |
| app |
1 |
|
|
|
|
|
|
|
|
communities |
6 |
| sensors |
1 |
|
|
|
|
|
|
|
|
radiation |
6 |
|
|
|
|
|
|
|
|
|
|
plasticity |
6 |
|
|
|
|
|
|
|
|
|
|
transition |
6 |
|
|
|
|
|
|
|
|
|
|
accessible |
6 |
|
|
|
|
|
|
|
|
|
|
require |
6 |
|
|
|
|
|
|
|
|
|
|
significantly |
6 |
|
|
|
|
|
|
|
|
|
|
influenza |
6 |
|
|
|
|
|
|
|
|
|
|
vaccines |
6 |
|
|
|
|
|
|
|
|
|
|
pathology |
6 |
|
|
|
|
|
|
|
|
|
|
antibodies |
6 |
|
|
|
|
|
|
|
|
|
|
fundamental |
6 |
|
|
|
|
|
|
|
|
|
|
radical |
6 |
|
|
|
|
|
|
|
|
|
|
requirements |
6 |
|
|
|
|
|
|
|
|
|
|
virulence |
6 |
|
|
|
|
|
|
|
|
|
|
broadly |
6 |
|
|
|
|
|
|
|
|
|
|
tissues |
6 |
|
|
|
|
|
|
|
|
|
|
efficiently |
6 |
|
|
|
|
|
|
|
|
|
|
good |
6 |
|
|
|
|
|
|
|
|
|
|
routine |
6 |
|
|
|
|
|
|
|
|
|
|
common |
6 |
|
|
|
|
|
|
|
|
|
|
lithium |
6 |
|
|
|
|
|
|
|
|
|
|
electronic |
5 |
|
|
|
|
|
|
|
|
|
|
fluorescence |
5 |
|
|
|
|
|
|
|
|
|
|
rise |
5 |
|
|
|
|
|
|
|
|
|
|
nutrient |
5 |
|
|
|
|
|
|
|
|
|
|
studying |
5 |
|
|
|
|
|
|
|
|
|
|
affected |
5 |
|
|
|
|
|
|
|
|
|
|
mutation |
5 |
|
|
|
|
|
|
|
|
|
|
specifically |
5 |
|
|
|
|
|
|
|
|
|
|
noise |
5 |
|
|
|
|
|
|
|
|
|
|
ratio |
5 |
|
|
|
|
|
|
|
|
|
|
true |
5 |
|
|
|
|
|
|
|
|
|
|
manner |
5 |
|
|
|
|
|
|
|
|
|
|
widely |
5 |
|
|
|
|
|
|
|
|
|
|
achieving |
5 |
|
|
|
|
|
|
|
|
|
|
review |
5 |
|
|
|
|
|
|
|
|
|
|
gold |
5 |
|
|
|
|
|
|
|
|
|
|
neurodegenerative |
5 |
|
|
|
|
|
|
|
|
|
|
disorders |
5 |
|
|
|
|
|
|
|
|
|
|
initiation |
5 |
|
|
|
|
|
|
|
|
|
|
discern |
5 |
|
|
|
|
|
|
|
|
|
|
biomarkers |
5 |
|
|
|
|
|
|
|
|
|
|
treating |
5 |
|
|
|
|
|
|
|
|
|
|
synaptic |
5 |
|
|
|
|
|
|
|
|
|
|
near |
5 |
|
|
|
|
|
|
|
|
|
|
ever |
5 |
|
|
|
|
|
|
|
|
|
|
relationship |
5 |
|
|
|
|
|
|
|
|
|
|
modifications |
5 |
|
|
|
|
|
|
|
|
|
|
sensor |
5 |
|
|
|
|
|
|
|
|
|
|
leading |
5 |
|
|
|
|
|
|
|
|
|
|
sars |
5 |
|
|
|
|
|
|
|
|
|
|
cov |
5 |
|
|
|
|
|
|
|
|
|
|
intensity |
5 |
|
|
|
|
|
|
|
|
|
|
devices |
5 |
|
|
|
|
|
|
|
|
|
|
strain |
5 |
|
|
|
|
|
|
|
|
|
|
applied |
5 |
|
|
|
|
|
|
|
|
|
|
acid |
5 |
|
|
|
|
|
|
|
|
|
|
residue |
5 |
|
|
|
|
|
|
|
|
|
|
technique |
5 |
|
|
|
|
|
|
|
|
|
|
soil |
5 |
|
|
|
|
|
|
|
|
|
|
conventional |
5 |
|
|
|
|
|
|
|
|
|
|
procedure |
5 |
|
|
|
|
|
|
|
|
|
|
tau |
5 |
|
|
|
|
|
|
|
|
|
|
mouse |
5 |
|
|
|
|
|
|
|
|
|
|
power |
5 |
|
|
|
|
|
|
|
|
|
|
proteomics |
5 |
|
|
|
|
|
|
|
|
|
|
limitations |
5 |
|
|
|
|
|
|
|
|
|
|
online |
5 |
|
|
|
|
|
|
|
|
|
|
technical |
5 |
|
|
|
|
|
|
|
|
|
|
distribution |
5 |
|
|
|
|
|
|
|
|
|
|
explore |
5 |
|
|
|
|
|
|
|
|
|
|
coupled |
5 |
|
|
|
|
|
|
|
|
|
|
extraction |
5 |
|
|
|
|
|
|
|
|
|
|
growing |
5 |
|
|
|
|
|
|
|
|
|
|
build |
5 |
|
|
|
|
|
|
|
|
|
|
wild |
5 |
|
|
|
|
|
|
|
|
|
|
developmental |
5 |
|
|
|
|
|
|
|
|
|
|
anatomical |
5 |
|
|
|
|
|
|
|
|
|
|
identified |
5 |
|
|
|
|
|
|
|
|
|
|
annotation |
5 |
|
|
|
|
|
|
|
|
|
|
body |
5 |
|
|
|
|
|
|
|
|
|
|
dose |
5 |
|
|
|
|
|
|
|
|
|
|
interpret |
5 |
|
|
|
|
|
|
|
|
|
|
lipid |
5 |
|
|
|
|
|
|
|
|
|
|
delivery |
5 |
|
|
|
|
|
|
|
|
|
|
vitro |
5 |
|
|
|
|
|
|
|
|
|
|
sensory |
5 |
|
|
|
|
|
|
|
|
|
|
importantly |
5 |
|
|
|
|
|
|
|
|
|
|
editing |
5 |
|
|
|
|
|
|
|
|
|
|
variety |
5 |
|
|
|
|
|
|
|
|
|
|
p |
5 |
|
|
|
|
|
|
|
|
|
|
ideally |
5 |
|
|
|
|
|
|
|
|
|
|
monitoring |
5 |
|
|
|
|
|
|
|
|
|
|
independent |
5 |
|
|
|
|
|
|
|
|
|
|
tb |
5 |
|
|
|
|
|
|
|
|
|
|
derived |
5 |
|
|
|
|
|
|
|
|
|
|
responsible |
5 |
|
|
|
|
|
|
|
|
|
|
progress |
5 |
|
|
|
|
|
|
|
|
|
|
clusters |
5 |
|
|
|
|
|
|
|
|
|
|
manipulate |
5 |
|
|
|
|
|
|
|
|
|
|
oxide |
5 |
|
|
|
|
|
|
|
|
|
|
treatments |
5 |
|
|
|
|
|
|
|
|
|
|
spectrum |
5 |
|
|
|
|
|
|
|
|
|
|
channel |
5 |
|
|
|
|
|
|
|
|
|
|
reconstruct |
5 |
|
|
|
|
|
|
|
|
|
|
scrna |
5 |
|
|
|
|
|
|
|
|
|
|
mode |
5 |
|
|
|
|
|
|
|
|
|
|
developing |
5 |
|
|
|
|
|
|
|
|
|
|
ct |
5 |
|
|
|
|
|
|
|
|
|
|
lpl |
5 |
|
|
|
|
|
|
|
|
|
|
architecture |
5 |
|
|
|
|
|
|
|
|
|
|
supramolecular |
5 |
|
|
|
|
|
|
|
|
|
|
native |
5 |
|
|
|
|
|
|
|
|
|
|
complexes |
5 |
|
|
|
|
|
|
|
|
|
|
precisely |
5 |
|
|
|
|
|
|
|
|
|
|
inhibitory |
5 |
|
|
|
|
|
|
|
|
|
|
laboratory |
5 |
|
|
|
|
|
|
|
|
|
|
isolation |
5 |
|
|
|
|
|
|
|
|
|
|
search |
5 |
|
|
|
|
|
|
|
|
|
|
metabolites |
5 |
|
|
|
|
|
|
|
|
|
|
live |
5 |
|
|
|
|
|
|
|
|
|
|
exhibits |
5 |
|
|
|
|
|
|
|
|
|
|
advantages |
5 |
|
|
|
|
|
|
|
|
|
|
final |
5 |
|
|
|
|
|
|
|
|
|
|
amyloid |
5 |
|
|
|
|
|
|
|
|
|
|
rather |
5 |
|
|
|
|
|
|
|
|
|
|
identifying |
5 |
|
|
|
|
|
|
|
|
|
|
appropriate |
5 |
|
|
|
|
|
|
|
|
|
|
allowing |
5 |
|
|
|
|
|
|
|
|
|
|
15 |
5 |
|
|
|
|
|
|
|
|
|
|
select |
5 |
|
|
|
|
|
|
|
|
|
|
remains |
5 |
|
|
|
|
|
|
|
|
|
|
choice |
5 |
|
|
|
|
|
|
|
|
|
|
robust |
5 |
|
|
|
|
|
|
|
|
|
|
room |
5 |
|
|
|
|
|
|
|
|
|
|
quickly |
5 |
|
|
|
|
|
|
|
|
|
|
first |
5 |
|
|
|
|
|
|
|
|
|
|
optimize |
5 |
|
|
|
|
|
|
|
|
|
|
trace |
5 |
|
|
|
|
|
|
|
|
|
|
person |
5 |
|
|
|
|
|
|
|
|
|
|
cognitive |
5 |
|
|
|
|
|
|
|
|
|
|
antibiotic |
5 |
|
|
|
|
|
|
|
|
|
|
agent |
5 |
|
|
|
|
|
|
|
|
|
|
determinants |
5 |
|
|
|
|
|
|
|
|
|
|
too |
5 |
|
|
|
|
|
|
|
|
|
|
together |
5 |
|
|
|
|
|
|
|
|
|
|
device |
5 |
|
|
|
|
|
|
|
|
|
|
receptors |
5 |
|
|
|
|
|
|
|
|
|
|
additionally |
5 |
|
|
|
|
|
|
|
|
|
|
flexible |
5 |
|
|
|
|
|
|
|
|
|
|
component |
5 |
|
|
|
|
|
|
|
|
|
|
nuclear |
5 |
|
|
|
|
|
|
|
|
|
|
transmission |
5 |
|
|
|
|
|
|
|
|
|
|
layer |
5 |
|
|
|
|
|
|
|
|
|
|
diet |
5 |
|
|
|
|
|
|
|
|
|
|
agents |
5 |
|
|
|
|
|
|
|
|
|
|
discuss |
5 |
|
|
|
|
|
|
|
|
|
|
em |
5 |
|
|
|
|
|
|
|
|
|
|
2d |
5 |
|
|
|
|
|
|
|
|
|
|
reduce |
5 |
|
|
|
|
|
|
|
|
|
|
implemented |
5 |
|
|
|
|
|
|
|
|
|
|
lower |
5 |
|
|
|
|
|
|
|
|
|
|
situ |
5 |
|
|
|
|
|
|
|
|
|
|
class |
5 |
|
|
|
|
|
|
|
|
|
|
20 |
5 |
|
|
|
|
|
|
|
|
|
|
connections |
5 |
|
|
|
|
|
|
|
|
|
|
biomarker |
5 |
|
|
|
|
|
|
|
|
|
|
inflammatory |
5 |
|
|
|
|
|
|
|
|
|
|
oxidation |
5 |
|
|
|
|
|
|
|
|
|
|
liquid |
5 |
|
|
|
|
|
|
|
|
|
|
phase |
5 |
|
|
|
|
|
|
|
|
|
|
step |
5 |
|
|
|
|
|
|
|
|
|
|
transcriptional |
5 |
|
|
|
|
|
|
|
|
|
|
alpha |
5 |
|
|
|
|
|
|
|
|
|
|
off |
5 |
|
|
|
|
|
|
|
|
|
|
imperative |
5 |
|
|
|
|
|
|
|
|
|
|
comprehensive |
5 |
|
|
|
|
|
|
|
|
|
|
lineages |
5 |
|
|
|
|
|
|
|
|
|
|
promotes |
5 |
|
|
|
|
|
|
|
|
|
|
damage |
5 |
|
|
|
|
|
|
|
|
|
|
microbial |
5 |
|
|
|
|
|
|
|
|
|
|
overall |
5 |
|
|
|
|
|
|
|
|
|
|
omics |
5 |
|
|
|
|
|
|
|
|
|
|
user |
5 |
|
|
|
|
|
|
|
|
|
|
greater |
5 |
|
|
|
|
|
|
|
|
|
|
association |
5 |
|
|
|
|
|
|
|
|
|
|
carbon |
5 |
|
|
|
|
|
|
|
|
|
|
vaccination |
5 |
|
|
|
|
|
|
|
|
|
|
age |
5 |
|
|
|
|
|
|
|
|
|
|
modern |
5 |
|
|
|
|
|
|
|
|
|
|
salt |
5 |
|
|
|
|
|
|
|
|
|
|
interaction |
5 |
|
|
|
|
|
|
|
|
|
|
phenotypes |
4 |
|
|
|
|
|
|
|
|
|
|
genetically |
4 |
|
|
|
|
|
|
|
|
|
|
revealed |
4 |
|
|
|
|
|
|
|
|
|
|
internal |
4 |
|
|
|
|
|
|
|
|
|
|
interact |
4 |
|
|
|
|
|
|
|
|
|
|
collect |
4 |
|
|
|
|
|
|
|
|
|
|
honey |
4 |
|
|
|
|
|
|
|
|
|
|
absence |
4 |
|
|
|
|
|
|
|
|
|
|
uniquely |
4 |
|
|
|
|
|
|
|
|
|
|
removed |
4 |
|
|
|
|
|
|
|
|
|
|
transcriptome |
4 |
|
|
|
|
|
|
|
|
|
|
overlap |
4 |
|
|
|
|
|
|
|
|
|
|
mitochondrial |
4 |
|
|
|
|
|
|
|
|
|
|
uptake |
4 |
|
|
|
|
|
|
|
|
|
|
nmr |
4 |
|
|
|
|
|
|
|
|
|
|
consuming |
4 |
|
|
|
|
|
|
|
|
|
|
makes |
4 |
|
|
|
|
|
|
|
|
|
|
insights |
4 |
|
|
|
|
|
|
|
|
|
|
challenges |
4 |
|
|
|
|
|
|
|
|
|
|
validity |
4 |
|
|
|
|
|
|
|
|
|
|
group |
4 |
|
|
|
|
|
|
|
|
|
|
peptides |
4 |
|
|
|
|
|
|
|
|
|
|
past |
4 |
|
|
|
|
|
|
|
|
|
|
decade |
4 |
|
|
|
|
|
|
|
|
|
|
treat |
4 |
|
|
|
|
|
|
|
|
|
|
individuals |
4 |
|
|
|
|
|
|
|
|
|
|
instead |
4 |
|
|
|
|
|
|
|
|
|
|
mixture |
4 |
|
|
|
|
|
|
|
|
|
|
air |
4 |
|
|
|
|
|
|
|
|
|
|
real |
4 |
|
|
|
|
|
|
|
|
|
|
exposure |
4 |
|
|
|
|
|
|
|
|
|
|
independently |
4 |
|
|
|
|
|
|
|
|
|
|
mechanical |
4 |
|
|
|
|
|
|
|
|
|
|
li |
4 |
|
|
|
|
|
|
|
|
|
|
partial |
4 |
|
|
|
|
|
|
|
|
|
|
neuron |
4 |
|
|
|
|
|
|
|
|
|
|
producing |
4 |
|
|
|
|
|
|
|
|
|
|
physiological |
4 |
|
|
|
|
|
|
|
|
|
|
neuroimaging |
4 |
|
|
|
|
|
|
|
|
|
|
b |
4 |
|
|
|
|
|
|
|
|
|
|
characterization |
4 |
|
|
|
|
|
|
|
|
|
|
content |
4 |
|
|
|
|
|
|
|
|
|
|
tree |
4 |
|
|
|
|
|
|
|
|
|
|
ranked |
4 |
|
|
|
|
|
|
|
|
|
|
d |
4 |
|
|
|
|
|
|
|
|
|
|
turn |
4 |
|
|
|
|
|
|
|
|
|
|
pharmacological |
4 |
|
|
|
|
|
|
|
|
|
|
dense |
4 |
|
|
|
|
|
|
|
|
|
|
nanometer |
4 |
|
|
|
|
|
|
|
|
|
|
occur |
4 |
|
|
|
|
|
|
|
|
|
|
diagnosis |
4 |
|
|
|
|
|
|
|
|
|
|
desirable |
4 |
|
|
|
|
|
|
|
|
|
|
amino |
4 |
|
|
|
|
|
|
|
|
|
|
susceptible |
4 |
|
|
|
|
|
|
|
|
|
|
spectrometry |
4 |
|
|
|
|
|
|
|
|
|
|
mixtures |
4 |
|
|
|
|
|
|
|
|
|
|
validation |
4 |
|
|
|
|
|
|
|
|
|
|
dataset |
4 |
|
|
|
|
|
|
|
|
|
|
uncertainty |
4 |
|
|
|
|
|
|
|
|
|
|
estimated |
4 |
|
|
|
|
|
|
|
|
|
|
differential |
4 |
|
|
|
|
|
|
|
|
|
|
ease |
4 |
|
|
|
|
|
|
|
|
|
|
shape |
4 |
|
|
|
|
|
|
|
|
|
|
marker |
4 |
|
|
|
|
|
|
|
|
|
|
case |
4 |
|
|
|
|
|
|
|
|
|
|
mortality |
4 |
|
|
|
|
|
|
|
|
|
|
driven |
4 |
|
|
|
|
|
|
|
|
|
|
part |
4 |
|
|
|
|
|
|
|
|
|
|
issues |
4 |
|
|
|
|
|
|
|
|
|
|
involvement |
4 |
|
|
|
|
|
|
|
|
|
|
cavity |
4 |
|
|
|
|
|
|
|
|
|
|
interplay |
4 |
|
|
|
|
|
|
|
|
|
|
rice |
4 |
|
|
|
|
|
|
|
|
|
|
emergence |
4 |
|
|
|
|
|
|
|
|
|
|
costs |
4 |
|
|
|
|
|
|
|
|
|
|
issue |
4 |
|
|
|
|
|
|
|
|
|
|
driving |
4 |
|
|
|
|
|
|
|
|
|
|
desired |
4 |
|
|
|
|
|
|
|
|
|
|
degradation |
4 |
|
|
|
|
|
|
|
|
|
|
typically |
4 |
|
|
|
|
|
|
|
|
|
|
drives |
4 |
|
|
|
|
|
|
|
|
|
|
second |
4 |
|
|
|
|
|
|
|
|
|
|
differences |
4 |
|
|
|
|
|
|
|
|
|
|
females |
4 |
|
|
|
|
|
|
|
|
|
|
contribute |
4 |
|
|
|
|
|
|
|
|
|
|
infer |
4 |
|
|
|
|
|
|
|
|
|
|
organization |
4 |
|
|
|
|
|
|
|
|
|
|
whereas |
4 |
|
|
|
|
|
|
|
|
|
|
studied |
4 |
|
|
|
|
|
|
|
|
|
|
media |
4 |
|
|
|
|
|
|
|
|
|
|
defined |
4 |
|
|
|
|
|
|
|
|
|
|
property |
4 |
|
|
|
|
|
|
|
|
|
|
organ |
4 |
|
|
|
|
|
|
|
|
|
|
analyze |
4 |
|
|
|
|
|
|
|
|
|
|
procedures |
4 |
|
|
|
|
|
|
|
|
|
|
serum |
4 |
|
|
|
|
|
|
|
|
|
|
enhance |
4 |
|
|
|
|
|
|
|
|
|
|
linear |
4 |
|
|
|
|
|
|
|
|
|
|
yeast |
4 |
|
|
|
|
|
|
|
|
|
|
impractical |
4 |
|
|
|
|
|
|
|
|
|
|
previously |
4 |
|
|
|
|
|
|
|
|
|
|
metabolism |
4 |
|
|
|
|
|
|
|
|
|
|
differentiation |
4 |
|
|
|
|
|
|
|
|
|
|
controlling |
4 |
|
|
|
|
|
|
|
|
|
|
mining |
4 |
|
|
|
|
|
|
|
|
|
|
science |
4 |
|
|
|
|
|
|
|
|
|
|
environments |
4 |
|
|
|
|
|
|
|
|
|
|
preclinical |
4 |
|
|
|
|
|
|
|
|
|
|
efficacy |
4 |
|
|
|
|
|
|
|
|
|
|
observe |
4 |
|
|
|
|
|
|
|
|
|
|
tuberculosis |
4 |
|
|
|
|
|
|
|
|
|
|
evaluation |
4 |
|
|
|
|
|
|
|
|
|
|
injury |
4 |
|
|
|
|
|
|
|
|
|
|
versatility |
4 |
|
|
|
|
|
|
|
|
|
|
entire |
4 |
|
|
|
|
|
|
|
|
|
|
last |
4 |
|
|
|
|
|
|
|
|
|
|
upon |
4 |
|
|
|
|
|
|
|
|
|
|
ring |
4 |
|
|
|
|
|
|
|
|
|
|
allow |
4 |
|
|
|
|
|
|
|
|
|
|
year |
4 |
|
|
|
|
|
|
|
|
|
|
behaviour |
4 |
|
|
|
|
|
|
|
|
|
|
sodium |
4 |
|
|
|
|
|
|
|
|
|
|
character |
4 |
|
|
|
|
|
|
|
|
|
|
identification |
4 |
|
|
|
|
|
|
|
|
|
|
voltage |
4 |
|
|
|
|
|
|
|
|
|
|
phosphorylation |
4 |
|
|
|
|
|
|
|
|
|
|
states |
4 |
|
|
|
|
|
|
|
|
|
|
secondary |
4 |
|
|
|
|
|
|
|
|
|
|
variations |
4 |
|
|
|
|
|
|
|
|
|
|
requires |
4 |
|
|
|
|
|
|
|
|
|
|
induce |
4 |
|
|
|
|
|
|
|
|
|
|
concentrations |
4 |
|
|
|
|
|
|
|
|
|
|
deep |
4 |
|
|
|
|
|
|
|
|
|
|
fusion |
4 |
|
|
|
|
|
|
|
|
|
|
locations |
4 |
|
|
|
|
|
|
|
|
|
|
accessibility |
4 |
|
|
|
|
|
|
|
|
|
|
competitive |
4 |
|
|
|
|
|
|
|
|
|
|
mice |
4 |
|
|
|
|
|
|
|
|
|
|
cause |
4 |
|
|
|
|
|
|
|
|
|
|
fully |
4 |
|
|
|
|
|
|
|
|
|
|
survival |
4 |
|
|
|
|
|
|
|
|
|
|
options |
4 |
|
|
|
|
|
|
|
|
|
|
whole |
4 |
|
|
|
|
|
|
|
|
|
|
spatially |
4 |
|
|
|
|
|
|
|
|
|
|
place |
4 |
|
|
|
|
|
|
|
|
|
|
training |
4 |
|
|
|
|
|
|
|
|
|
|
apply |
4 |
|
|
|
|
|
|
|
|
|
|
persons |
4 |
|
|
|
|
|
|
|
|
|
|
solid |
4 |
|
|
|
|
|
|
|
|
|
|
isolate |
4 |
|
|
|
|
|
|
|
|
|
|
kinetics |
4 |
|
|
|
|
|
|
|
|
|
|
outcomes |
4 |
|
|
|
|
|
|
|
|
|
|
antibody |
4 |
|
|
|
|
|
|
|
|
|
|
capacity |
4 |
|
|
|
|
|
|
|
|
|
|
close |
4 |
|
|
|
|
|
|
|
|
|
|
14 |
4 |
|
|
|
|
|
|
|
|
|
|
error |
4 |
|
|
|
|
|
|
|
|
|
|
tracking |
4 |
|
|
|
|
|
|
|
|
|
|
ray |
4 |
|
|
|
|
|
|
|
|
|
|
generally |
4 |
|
|
|
|
|
|
|
|
|
|
toward |
4 |
|
|
|
|
|
|
|
|
|
|
demonstrated |
4 |
|
|
|
|
|
|
|
|
|
|
band |
4 |
|
|
|
|
|
|
|
|
|
|
ev |
4 |
|
|
|
|
|
|
|
|
|
|
uncover |
4 |
|
|
|
|
|
|
|
|
|
|
peaks |
4 |
|
|
|
|
|
|
|
|
|
|
100 |
4 |
|
|
|
|
|
|
|
|
|
|
parasite |
4 |
|
|
|
|
|
|
|
|
|
|
prediction |
4 |
|
|
|
|
|
|
|
|
|
|
day |
4 |
|
|
|
|
|
|
|
|
|
|
pair |
4 |
|
|
|
|
|
|
|
|
|
|
residues |
4 |
|
|
|
|
|
|
|
|
|
|
phenotype |
4 |
|
|
|
|
|
|
|
|
|
|
physical |
4 |
|
|
|
|
|
|
|
|
|
|
infections |
4 |
|
|
|
|
|
|
|
|
|
|
variants |
4 |
|
|
|
|
|
|
|
|
|
|
emissions |
4 |
|
|
|
|
|
|
|
|
|
|
separation |
4 |
|
|
|
|
|
|
|
|
|
|
until |
4 |
|
|
|
|
|
|
|
|
|
|
lens |
4 |
|
|
|
|
|
|
|
|
|
|
affect |
4 |
|
|
|
|
|
|
|
|
|
|
then |
4 |
|
|
|
|
|
|
|
|
|
|
predictions |
4 |
|
|
|
|
|
|
|
|
|
|
alterations |
4 |
|
|
|
|
|
|
|
|
|
|
pathogens |
4 |
|
|
|
|
|
|
|
|
|
|
block |
4 |
|
|
|
|
|
|
|
|
|
|
mg |
4 |
|
|
|
|
|
|
|
|
|
|
l |
4 |
|
|
|
|
|
|
|
|
|
|
conformations |
4 |
|
|
|
|
|
|
|
|
|
|
another |
4 |
|
|
|
|
|
|
|
|
|
|
straightforward |
4 |
|
|
|
|
|
|
|
|
|
|
input |
4 |
|
|
|
|
|
|
|
|
|
|
enhanced |
4 |
|
|
|
|
|
|
|
|
|
|
lung |
4 |
|
|
|
|
|
|
|
|
|
|
caused |
4 |
|
|
|
|
|
|
|
|
|
|
transcription |
4 |
|
|
|
|
|
|
|
|
|
|
domains |
4 |
|
|
|
|
|
|
|
|
|
|
output |
4 |
|
|
|
|
|
|
|
|
|
|
cortex |
4 |
|
|
|
|
|
|
|
|
|
|
solar |
4 |
|
|
|
|
|
|
|
|
|
|
surfaces |
4 |
|
|
|
|
|
|
|
|
|
|
thermal |
4 |
|
|
|
|
|
|
|
|
|
|
transparent |
4 |
|
|
|
|
|
|
|
|
|
|
sensors |
4 |
|
|
|
|
|
|
|
|
|
|
controlled |
4 |
|
|
|
|
|
|
|
|
|
|
varying |
4 |
|
|
|
|
|
|
|
|
|
|
synthetic |
4 |
|
|
|
|
|
|
|
|
|
|
symptoms |
4 |
|
|
|
|
|
|
|
|
|
|
immortalization |
4 |
|
|
|
|
|
|
|
|
|
|
product |
4 |
|
|
|
|
|
|
|
|
|
|
presence |
4 |
|
|
|
|
|
|
|
|
|
|
assessment |
4 |
|
|
|
|
|
|
|
|
|
|
variation |
4 |
|
|
|
|
|
|
|
|
|
|
mri |
4 |
|
|
|
|
|
|
|
|
|
|
designed |
4 |
|
|
|
|
|
|
|
|
|
|
components |
4 |
|
|
|
|
|
|
|
|
|
|
strains |
4 |
|
|
|
|
|
|
|
|
|
|
optimized |
4 |
|
|
|
|
|
|
|
|
|
|
pancreatic |
4 |
|
|
|
|
|
|
|
|
|
|
best |
4 |
|
|
|
|
|
|
|
|
|
|
cryo |
4 |
|
|
|
|
|
|
|
|
|
|
theory |
4 |
|
|
|
|
|
|
|
|
|
|
market |
4 |
|
|
|
|
|
|
|
|
|
|
fruit |
4 |
|
|
|
|
|
|
|
|
|
|
subtypes |
4 |
|
|
|
|
|
|
|
|
|
|
dimensional |
4 |
|
|
|
|
|
|
|
|
|
|
harder |
4 |
|
|
|
|
|
|
|
|
|
|
dysfunction |
4 |
|
|
|
|
|
|
|
|
|
|
upper |
4 |
|
|
|
|
|
|
|
|
|
|
appear |
4 |
|
|
|
|
|
|
|
|
|
|
window |
4 |
|
|
|
|
|
|
|
|
|
|
deeply |
4 |
|
|
|
|
|
|
|
|
|
|
building |
4 |
|
|
|
|
|
|
|
|
|
|
matter |
4 |
|
|
|
|
|
|
|
|
|
|
gut |
4 |
|
|
|
|
|
|
|
|
|
|
inter |
4 |
|
|
|
|
|
|
|
|
|
|
physiology |
4 |
|
|
|
|
|
|
|
|
|
|
amenable |
4 |
|
|
|
|
|
|
|
|
|
|
developments |
4 |
|
|
|
|
|
|
|
|
|
|
hsv |
4 |
|
|
|
|
|
|
|
|
|
|
relative |
4 |
|
|
|
|
|
|
|
|
|
|
offers |
4 |
|
|
|
|
|
|
|
|
|
|
address |
4 |
|
|
|
|
|
|
|
|
|
|
details |
4 |
|
|
|
|
|
|
|
|
|
|
enhancement |
4 |
|
|
|
|
|
|
|
|
|
|
pathogenesis |
4 |
|
|
|
|
|
|
|
|
|
|
narrow |
4 |
|
|
|
|
|
|
|
|
|
|
vulnerable |
4 |
|
|
|
|
|
|
|
|
|
|
morphological |
4 |
|
|
|
|
|
|
|
|
|
|
chemistry |
4 |
|
|
|
|
|
|
|
|
|
|
led |
4 |
|
|
|
|
|
|
|
|
|
|
chain |
4 |
|
|
|
|
|
|
|
|
|
|
13 |
4 |
|
|
|
|
|
|
|
|
|
|
oxidative |
4 |
|
|
|
|
|
|
|
|
|
|
shelf |
4 |
|
|
|
|
|
|
|
|
|
|
computationally |
4 |
|
|
|
|
|
|
|
|
|
|
21 |
4 |
|
|
|
|
|
|
|
|
|
|
coating |
4 |
|
|
|
|
|
|
|
|
|
|
great |
4 |
|
|
|
|
|
|
|
|
|
|
reduction |
4 |
|
|
|
|
|
|
|
|
|
|
adaptive |
4 |
|
|
|
|
|
|
|
|
|
|
retina |
4 |
|
|
|
|
|
|
|
|
|
|
run |
4 |
|
|
|
|
|
|
|
|
|
|
persistent |
4 |
|
|
|
|
|
|
|
|
|
|
fluctuations |
4 |
|
|
|
|
|
|
|
|
|
|
pro |
4 |
|
|
|
|
|
|
|
|
|
|
vary |
4 |
|
|
|
|
|
|
|
|
|
|
disordered |
4 |
|
|
|
|
|
|
|
|
|
|
plays |
4 |
|
|
|
|
|
|
|
|
|
|
pathogen |
4 |
|
|
|
|
|
|
|
|
|
|
feature |
4 |
|
|
|
|
|
|
|
|
|
|
biomass |
4 |
|
|
|
|
|
|
|
|
|
|
humans |
4 |
|
|
|
|
|
|
|
|
|
|
signals |
4 |
|
|
|
|
|
|
|
|
|
|
countries |
4 |
|
|
|
|
|
|
|
|
|
|
indicate |
4 |
|
|
|
|
|
|
|
|
|
|
cm |
4 |
|
|
|
|
|
|
|
|
|
|
enables |
4 |
|
|
|
|
|
|
|
|
|
|
markers |
4 |
|
|
|
|
|
|
|
|
|
|
changing |
4 |
|
|
|
|
|
|
|
|
|
|
personalized |
4 |
|
|
|
|
|
|
|
|
|
|
frequencies |
4 |
|
|
|
|
|
|
|
|
|
|
theoretical |
4 |
|
|
|
|
|
|
|
|
|
|
public |
4 |
|
|
|
|
|
|
|
|
|
|
extract |
4 |
|
|
|
|
|
|
|
|
|
|
stimuli |
4 |
|
|
|
|
|
|
|
|
|
|
reproducible |
4 |
|
|
|
|
|
|
|
|
|
|
providing |
4 |
|
|
|
|
|
|
|
|
|
|
flexibility |
4 |
|
|
|
|
|
|
|
|
|
|
conversion |
4 |
|
|
|
|
|
|
|
|
|
|
showing |
4 |
|
|
|
|
|
|
|
|
|
|
combined |
4 |
|
|
|
|
|
|
|
|
|
|
text |
4 |
|
|
|
|
|
|
|
|
|
|
sizes |
4 |
|
|
|
|
|
|
|
|
|
|
extent |
4 |
|
|
|
|
|
|
|
|
|
|
somatic |
4 |
|
|
|
|
|
|
|
|
|
|
microfluidic |
4 |
|
|
|
|
|
|
|
|
|
|
melanoma |
4 |
|
|
|
|
|
|
|
|
|
|
history |
4 |
|
|
|
|
|
|
|
|
|
|
30 |
4 |
|
|
|
|
|
|
|
|
|
|
decades |
4 |
|